Haines MS, Kimball A, Meenaghan E, Bachmann KN, et al. Sequential therapy with recombinant human IGF-1 followed by risedronate increases spine bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled trial. J Bone Miner Res 2021 Aug 6. doi: 10.1002/jbmr.4420.
PMID: 34355814